Management

  • A. J. Kazimi

    Chief Executive Officer
    Chief Executive Officer

    Mr. Kazimi founded Cumberland Pharmaceuticals in 1999 and has served as Chief Executive Officer and Chairman of the Board of Directors since its inception. Prior to forming Cumberland, he served as President and Chief Operating Officer of Therapeutic Antibodies Inc., a biopharmaceutical company. During his 11 years with the company, Mr. Kazimi oversaw operations in three countries and played a key role in the company’s product development strategies, licensing and distribution agreements, and the raising of more than $100 million through equity and debt financings, as well as its initial public offering. Earlier in his career, he worked at Brown-Forman Corporation, rising through a series of management positions. Mr. Kazimi currently serves on the board of directors for the Nashville Health Care Council, an industry association representing the largest concentration of healthcare companies in the United States and has served on the board for Aegis Toxicology Sciences Corporation, a federally certified forensic toxicology laboratory. He also serves as Chairman and Chief Executive Officer of Cumberland Emerging Technologies, Inc. (CET). He holds a B.S. from the University of Notre Dame and an M.B.A. from the Vanderbilt Owen Graduate School of Management.

    .

    • Martin E. Cearnal

      Executive Vice President & Chief Commercial Officer
      Executive Vice President & Chief Commercial Officer

      Mr. Cearnal has served as a member of our Board of Directors since 2004. In 2008, he joined our management team to head commercial development for Cumberland, currently serving as Executive Vice President and Chief Commercial Officer. He is the former President and Chief Executive Officer of Physicians World, which became the largest provider of continuing medical education during his tenure from 1985 to 2000. Physicians World was acquired by Thomson Healthcare in 2000, and Mr. Cearnal served as President of Thomson Physicians World from 2000 to 2003 and Executive Vice President-Chief Strategy Officer for Thomson Medical Education from 2003 through 2005. He then became Executive Vice President-Chief Strategy Officer for Jobson Medical Information. Mr. Cearnal has over 50 years of experience in the healthcare industry and has been involved with the launches of such noteworthy pharmaceutical products as Lipitor®, Actos®, Intron-A®, Straterra®, Botox® and Humira®. He spent 17 years at Revlon Healthcare in a variety of domestic and international pharmaceutical marketing roles culminating in his position as Vice President, Marketing for International Operations. He has a B.S. degree from Southeast Missouri State University. The Board believes Mr. Cearnal brings significant marketing-related knowledge to the Company, which has and will help facilitate successful product launches and marketing plans, among other contributions.

      • Leo Pavliv, R.Ph.

        Executive Vice President, Operations & Chief Development Officer
        Executive Vice President, Operations & Chief Development Officer

        As Executive Vice President of Operations & Chief Development Officer, Mr. Pavliv is responsible for Cumberland’s overall drug development, including manufacturing and quality operations. Prior to joining Cumberland in 2003, he spent six years at Cato Research, a contract research organization where he served in a variety of positions, including Vice President of Pharmaceutical Development. Previously, he held scientific and management positions at both large pharmaceutical and smaller biopharmaceutical firms including Parke-Davis, Agouron Pharmaceuticals, ProCyte, and Interferon Sciences. He is a registered pharmacist (R.Ph.)

        • Michael Bonner

          Senior Director Finance & Accounting and Chief Financial Officer
          Senior Director Finance & Accounting and Chief Financial Officer

          Michael Bonner joined Cumberland Pharmaceuticals Inc. as Director, Financial and Tax Reporting during 2013 and directs the preparation and filing of all SEC communications along with the identification and research of technical accounting issues. He directs all Sarbanes-Oxley compliance activities including the primary interaction with internal and external auditors and directs all tax activities and tax services with external tax professionals. He has 13 years of experience in financial management, accounting and reporting, primarily within the health care industry. Prior to joining Cumberland, Mr. Bonner worked for over six years with Advocat Inc., a NASDAQ listed skilled nursing services provider, as Vice President of Accounting and Financial Reporting. Prior to that, Mr. Bonner served in a financial reporting role at LifePoint Hospitals Inc., a NASDAQ listed acute care hospital company, and spent close to five years in the assurance practice at Ernst & Young. A Certified Public Accountant, Mr. Bonner holds both a Bachelor of Science in Accounting and a Masters of Business Administration from Troy University.

          • James L. Herman

            Senior Vice President, National Accounts & Chief Compliance Officer
            Senior Vice President, National Accounts & Chief Compliance Officer

            As Senior Vice President of National Accounts, Mr. Herman handles all national sales, including wholesalers and retail chain buying offices, managed care home offices and federal government accounts. He also oversees corporate compliance efforts. Previously, he was with Solvay Pharmaceuticals where he served as Director of Managed Care, as well as Director of Trade Affairs and Customer Service. Earlier in his career, Mr. Herman spent eight years with Schwarz Pharma, where he held national sales leadership positions. He holds a B.S. from Indiana University and an M.B.A. from Cardinal Stritch University.

            • Adam Haeberle Ph.D. MBA

              Senior Director, Clinical & Regulatory Affairs
              Senior Director, Clinical & Regulatory Affairs

              Dr. Haeberle joined Cumberland in 2018 from Amgen Inc., the world’s largest biopharmaceutical company, where he held a series of director level clinical development roles. Now at Cumberland as the Senior Director, Clinical & Regulatory Affairs, he is responsible for overseeing our product development team in support of their efforts to design and implement our clinical studies to advance our pipeline. Dr. Haeberle earned his bachelor’s degree in biology from John Hopkins University and a doctorate in neuroscience with a concentration in cell and molecular biology from Louisiana State University Health Sciences Center. He also completed a master’s degree in business administration from Pepperdine University.

              • Adam Mostafa

                Managing Director, Consultant
                Managing Director, Consultant

                In his role as a Managing Director, Mr. Mostafa is responsible for managing our investment banking activities and supporting our institutional investor interactions. Adam is an experienced biopharmaceutical investment banker who has worked for over 17 years in corporate finance. Prior to joining Cumberland in 2017, Mr. Mostafa worked on Wall Street at Cantor Fitzgerald & Co. as Managing Director, Healthcare Investment Banking. There, he was involved predominantly in financing life sciences companies in the specialty pharmaceutical and biotechnology sectors. He also served as a senior healthcare investment banker at both Needham & Company and CRT Capital, where at the latter he was also involved in life sciences private equity investments. Earlier in his career, Adam was a portfolio management associate at AQR Capital and a healthcare investment banking analyst at Salomon Smith Barney. Mr. Mostafa graduated from Brown University with a degree in Economics.

                • Cindy Patton

                  Senior Director, Field Marketing
                  Senior Director, Field Marketing

                  Ms. Patton began her industry career as a Ciba Geigy sales representative in 1983. Relocating to the Ciba Geigy corporate office in 1991, she served in the Customer Marketing Group, becoming the Director of Institutional Marketing in 1995. Following the merger that created Novartis, she held positions which included Lotensin Product Director and Ciba Novartis Sales Director for the New York Region. She graduated magna cum laude from Lambuth College with a B.B.A.

                  • Barry L. Lee

                    Senior Director, Hospital Products
                    Senior Director, Hospital Products

                    In his role as Senior Director, Hospital Products, Mr. Lee is responsible for all marketing activities associated with the commercialization of Caldolor®, the company’s intravenous formulation of ibuprofen. Prior to joining the company in 2008, he spent 24 years with Bayer Healthcare Pharmaceuticals, Inc. There he held a variety of pharmaceutical sales and marketing positions and, most notably, was responsible for the launch of Yasmin® in 2001—one of the most successful industry product launches at that time. He earned a B.S. degree from Texas A&M University.

                    • Todd Anthony

                      Executive Director, Organizational Development
                      Executive Director, Organizational Development

                      Mr. Anthony joined our company in 2010 and is Executive Director, Organizational Development. He is responsible for all training activities related to product knowledge and selling skills for our Sales Organization, as well as sales management, corporate training, and leadership development. He began his pharmaceutical career with Berlex Laboratories Inc. in 1991 and spent 19 years at that company which is now Bayer HealthCare Pharmaceuticals following the 2006 acquisition of Schering AG. While there he held positions of increasing responsibility including roles in Sales, Sales Training, Sales Management and Corporate Management/Leadership development. He has a BSN degree from D’Youville College in Buffalo, NY..

                      • Tan Cheow Choon

                        Senior Director, International Business
                        Senior Director, International Business

                        Mr. Tan is the Senior Director of International Business Development for Cumberland Pharmaceuticals. His responsibilities include identifying new partnership opportunities and managing those relationships in the Asian market. Prior to joining Cumberland, he was Vice President of Southeast Asia & Korea at Hospira Inc. His career also includes roles in banking & finance with the United Overseas Bank, Singapore as well as the establishment, development & management of pharmaceutical partnerships across Asia as General Manager, Asia for Mayne & Faulding Pharmaceutical of Australia. Mr. Tan is an Accountant, earning his Bachelor of Accountancy from the National University of Singapore and an MBA from Monash University in Australia.

                        • Michael Schulz

                          Manager, Government & Community Affairs
                          Manager, Government & Community Affairs

                          Mr. Schulz joined our company in 2017 as Manager, Government & Community Affairs. His responsibilities include launching and overseeing the Cumberland Pharma Foundation, the Cumberland Health & Wellness Political Action Committee, and various other corporate governmental and community initiatives. He comes to Cumberland from a local Nashville investment fund where his duties encompassed investor outreach and working with the Securities and Exchange Commission, Financial Industry Regulatory Authority, and the New York Stock Exchange. Prior to that, he spent ten years in the Office of Senator Lamar Alexander with responsibilities that included liaising with Governor’s staff, state officials, Tennessee legislators, and various other elected officials. He earned his bachelor’s degree in political science from Middle Tennessee State University. He also serves as Chairman on Nashville Emerging Leaders’ Board of Directors.

                          • Kenny Acevedo

                            Field Sales Director
                            Field Sales Director

                            Prior to joining Cumberland 2011, Mr. Acevedo served as Hospital District Manager, Senior District Manager and Cardio Metabolic Specialty Manager for Novartis Pharmaceuticals. During his 20- year tenure, the company ranked as one of the largest pharmaceutical companies in the world. Mr. Acevedo has been involved in the launching of such noteworthy pharmaceutical products as Diovan, Lotrel, Lopressor XL, Lotensin, Lescol XL Voltaren, and Estraderm. He spent 5 years at ICN Pharmaceuticals as Regional Director for the West Coast. He is a graduate of New York State University at Stony Brook and he also received his Master’s in Health Administration from Long Island University.

                            • Chris Bitterman

                              Hospital Sales Director
                              Hospital Sales Director

                              Mr. Bitterman joined Cumberland in 2018 with a distinguished career in Acute Care and pharmaceutical sales management spanning over 25 years. Highlights include his roles as National Sales Director for Daiichi Sankyo and Regional Sales Director for Sanofi Aventis. Prior to Cumberland, Mr. Bitterman was employed at Lupin Pharmaceuticals as National Sales Director, leading the commercialization efforts for their Women’s Healthcare portfolio. As Cumberland’s Hospital Sales Director, he is responsible for leading our veteran Hospital Sales division, the development & execution of team business priorities, and delivering the financial objectives for our Hospital products. A native of Detroit, Michigan, Mr. Bitterman earned his bachelor’s and master’s degree in Business from Central Michigan University.